GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Pharmalabs Ltd (BOM:543748) » Definitions » YoY EPS Growth

Aarti Pharmalabs (BOM:543748) YoY EPS Growth : 35.28% (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Aarti Pharmalabs YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Aarti Pharmalabs's YoY EPS Growth for the quarter that ended in Mar. 2025 was 35.28%.

Aarti Pharmalabs's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was ₹9.74.

Aarti Pharmalabs YoY EPS Growth Historical Data

The historical data trend for Aarti Pharmalabs's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Pharmalabs YoY EPS Growth Chart

Aarti Pharmalabs Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
YoY EPS Growth
- 1,349,100.00 58.27 12.08 25.53

Aarti Pharmalabs Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.19 17.69 5.24 40.21 35.28

Aarti Pharmalabs YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Aarti Pharmalabs's YoY EPS Growth for the fiscal year that ended in Mar. 2025 is calculated as:

YoY EPS Growth (A: Mar. 2025 )
=(Earnings per Share (Diluted) (A: Mar. 2025 )-Earnings per Share (Diluted) (A: Mar. 2024 ))/ | Earnings per Share (Diluted) (A: Mar. 2024 ) |
=(30.04-23.93)/ | 23.93 |
=25.53 %

Aarti Pharmalabs's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EPS Growth (Q: Mar. 2025 )
=(Earnings per Share (Diluted) (Q: Mar. 2025 )-Earnings per Share (Diluted) (Q: Mar. 2024 )) / | Earnings per Share (Diluted) (Q: Mar. 2024 )) |
=(9.74-7.2)/ | 7.2 |
=35.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aarti Pharmalabs YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Aarti Pharmalabs's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Aarti Pharmalabs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Pharmalabs Ltd (BOM:543748) » Definitions » YoY EPS Growth
Comparable Companies
BOM:530549 BOM:531599 NSE:STAR BOM:544222 NSE:INNOVACAP BOM:524735 BOM:500126 BOM:532872 BOM:506690 BOM:524372 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
AARTIPHARM:India
Address
Mulund Goregaon Link Road, 2nd floor, 204, Udyog Kshetra, Mulund West, Mumbai, MH, IND, 400080
Website
https://www.aartipharmalabs.com
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, and xanthine derivatives in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.

Aarti Pharmalabs Headlines

No Headlines